- Revolutionary drug promises to ‘melt away’ bowel cancer tumors, doctors say Ynetnews
- Drug that ‘melts away’ tumours hailed as ‘gamechanger’ for some bowel cancer patients The Guardian
- GSK’s Jemperli shows potential in Phase II rectal cancer trial Clinical Trials Arena
- Dostarlimab 2 for 2: Snagging 100% Clinical CR in dMMR Locally Advanced Rectal Cancer OncLive
- Jemperli (dostarlimab-gxly) trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced mismatch repair deficient (dMMR) rectal cancer Yahoo Finance
Read original article here